MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury.

The Sur1-Trpm4 Channel in Spinal Cord Injury. J Spine (2013) 0.84

Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol (2014) 0.79

Serial Diffusion Tensor Imaging In Vivo Predicts Long-Term Functional Recovery and Histopathology in Rats following Different Severities of Spinal Cord Injury. J Neurotrauma (2016) 0.76

A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury. J Neurotrauma (2015) 0.75

Creation of an intramedullary cavity by hemorrhagic necrosis removal 24 h after spinal cord contusion in rats for eventual intralesional implantation of restorative materials. PLoS One (2017) 0.75

A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48

Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord (2006) 3.87

Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med (2006) 2.57

Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest (2007) 1.84

Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke (2008) 1.64

De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med (2009) 1.42

Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest (1978) 1.41

Graded unilateral cervical spinal cord injury in the rat: evaluation of forelimb recovery and histological effects. Behav Brain Res (2001) 1.41

Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med (2010) 1.28

Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury. Exp Neurol (2010) 1.28

Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp Neurol (1999) 1.23

The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem (2012) 1.18

A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma (2013) 1.13

Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol (2011) 1.11

Glibenclamide-10-h Treatment Window in a Clinically Relevant Model of Stroke. Transl Stroke Res (2012) 1.10

Histopathologic correlation of magnetic resonance imaging signal patterns in a spinal cord injury model. Spine (Phila Pa 1976) (1990) 1.06

The unique histopathological responses of the injured spinal cord. Implications for neuroprotective therapy. Ann N Y Acad Sci (1999) 1.02

Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine (2012) 1.00

Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma (2013) 0.96

Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: in vivo magnetic resonance imaging. Magn Reson Med (2000) 0.94

[Experimental study of acute spinal cord injury: a histopathological study]. No Shinkei Geka (1993) 0.90

The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity. Brain Sci (2013) 0.88

Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide. Exp Neurol (2011) 0.86

Experimental study on MRI evaluation of the course of cervical spinal cord injury. Spinal Cord (1999) 0.83

Neuroprotective effects of riluzole in neurotrauma models: a review. Acta Neurochir Suppl (1999) 0.82

Intramedullary lesion expansion on magnetic resonance imaging in patients with motor complete cervical spinal cord injury. J Neurosurg Spine (2012) 0.82

Microcapsules and transdermal patch: a comparative approach for improved delivery of antidiabetic drug. AAPS PharmSciTech (2009) 0.82

Experimental spinal cord injury: MR correlation to intensity of injury. J Comput Assist Tomogr (1994) 0.80

Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery (2000) 2.55

Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma (2000) 1.97

Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem (1996) 1.80

Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol (1994) 1.68

Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66

The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology (1997) 1.55

Patterns of DNA sequence variation in chromosomally recognized taxa of Anopheles gambiae: evidence from rDNA and single-copy loci. Insect Mol Biol (2001) 1.53

Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol (1998) 1.49

Regional intensive and temporal patterns of functional MRI activation distinguishing noxious and innocuous contact heat. J Neurophysiol (2004) 1.39

Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol (1994) 1.39

Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des (2005) 1.33

Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci (1997) 1.32

Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience (2008) 1.30

Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther (1997) 1.29

On the excitatory effects of ATP and its role as a neurotransmitter in coeliac neurons of the guinea-pig. J Physiol (1993) 1.29

Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma (2002) 1.28

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. Aliment Pharmacol Ther (2011) 1.21

Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol (1997) 1.21

Diffusion tensor MR imaging in cervical spine trauma. AJNR Am J Neuroradiol (2008) 1.20

Somatotopy in human primary motor and somatosensory hand representations revisited. Cereb Cortex (2001) 1.19

ATP mediates excitatory synaptic transmission in mammalian neurones. Br J Pharmacol (1992) 1.18

Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J Pharmacol Exp Ther (1998) 1.16

Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells. J Gen Physiol (2001) 1.14

Neuronal nicotinic receptor subtypes. Ann N Y Acad Sci (1995) 1.11

ATP closes a potassium and opens a cationic conductance through different receptors in neurons of guinea pig submucous plexus. J Pharmacol Exp Ther (1994) 0.97

Evaluation of percutaneous transhepatic balloon dilatation of benign biliary strictures in high-risk patients. Am J Surg (1985) 0.94

P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties. Br J Pharmacol (1996) 0.91

Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp Neurol (2000) 0.89

Robust axonal growth and a blunted macrophage response are associated with impaired functional recovery after spinal cord injury in the MRL/MpJ mouse. Neuroscience (2008) 0.88

Reporter epitopes: a novel approach to examine transmembrane topology of integral membrane proteins applied to the alpha 1 subunit of the nicotinic acetylcholine receptor. Biochemistry (1993) 0.85

Strategies for spinal cord injury repair. Prog Brain Res (2000) 0.84

Molecular and antigenic structure of nicotinic acetylcholine receptors. Ann N Y Acad Sci (1998) 0.83

Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR. J Neurotrauma (1995) 0.82

Non-invasive electrical stimulation of the brain (ESB) modifies the resting-state network connectivity of the primary motor cortex: a proof of concept fMRI study. Brain Res (2011) 0.81

Determinants of channel gating located in the N-terminal extracellular domain of nicotinic alpha7 receptor. J Pharmacol Exp Ther (1998) 0.79

Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain. Gene Ther (2012) 0.77

A quantitative spatial analysis of the blood-spinal cord barrier. II. Permeability after intraspinal fetal transplantation. Exp Neurol (1996) 0.75

Percutaneous transpouch management of a ureteral stone and ureteral-pouch stricture in a pelvic kidney. Urology (2001) 0.75

T1-weighted three-dimensional magnetization transfer MR of the brain: improved lesion contrast enhancement. AJNR Am J Neuroradiol (1998) 0.75

Gallium nitrate and spinal cord injury. A pilot study of efficacy using an experimental model. Paraplegia (1994) 0.75